Randomized Clinical Trial of SARS-CoV-2 Peri-Vaccination Immunosuppressive Reduction in Kidney and Liver Transplant Recipients
William A. Werbel(Johns Hopkins University), Christine M. Durand(University of Maryland, Baltimore), Meenakshi Rana(Icahn School of Medicine at Mount Sinai), Scott Borgetti, Natasha Watson(National Institutes of Health), J. Garonzik Wang, Emily A. Blumberg(University of Pennsylvania), Allan B. Massie(Johns Hopkins University), Lucy Li(National Institutes of Health), Dorry L. Segev(New York University), S. Aslam, Diane Brown(Johns Hopkins University), Sanaz Daneshfar Hamrah(Johns Hopkins University), Christian P. Larsen(Emory University Hospital), Maxwell A. Fung, Aaron A.R. Tobian(Johns Hopkins University), Andrew H. Karaba(Johns Hopkins University), Brittany Barnaba(Johns Hopkins University), Catherine B. Small(Cornell University), Marcelo Bettinotti(Shri Jagdishprasad Jhabarmal Tibrewala University), Peter S. Heeger(Cedars-Sinai Medical Center), William Clarke(Johns Hopkins University), Zeba Nauroz(Johns Hopkins University), Stephanie M. Pouch(Emory University)
Cited by 0
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k